TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 84 filers reported holding TG THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $5,480,000 | -30.9% | 1,178,520 | +15.1% | 0.00% | -50.0% |
| Q3 2016 | $7,927,000 | +35.0% | 1,024,196 | +5.7% | 0.00% | +100.0% |
| Q2 2016 | $5,872,000 | -29.8% | 968,987 | -1.3% | 0.00% | -50.0% |
| Q1 2016 | $8,363,000 | -26.9% | 981,545 | +2.4% | 0.00% | -33.3% |
| Q4 2015 | $11,439,000 | +21.8% | 958,833 | +2.9% | 0.00% | +50.0% |
| Q3 2015 | $9,395,000 | -39.1% | 932,054 | +0.2% | 0.00% | -50.0% |
| Q2 2015 | $15,434,000 | +23.1% | 930,330 | +14.9% | 0.00% | +33.3% |
| Q1 2015 | $12,534,000 | +3.6% | 809,701 | +6.0% | 0.00% | 0.0% |
| Q4 2014 | $12,097,000 | +105.7% | 763,724 | +38.6% | 0.00% | +50.0% |
| Q3 2014 | $5,881,000 | +10.5% | 551,171 | -2.8% | 0.00% | +100.0% |
| Q2 2014 | $5,324,000 | +68.1% | 566,987 | +23.5% | 0.00% | 0.0% |
| Q1 2014 | $3,168,000 | +81.1% | 459,061 | +2.4% | 0.00% | 0.0% |
| Q4 2013 | $1,749,000 | -21.7% | 448,445 | +1.2% | 0.00% | 0.0% |
| Q3 2013 | $2,233,000 | +20.8% | 443,035 | +53.1% | 0.00% | 0.0% |
| Q2 2013 | $1,849,000 | – | 289,316 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 6,880,323 | $38,633,000 | 2.30% |
| Eversept Partners, LP | 773,501 | $4,343,208 | 1.35% |
| Opaleye Management Inc. | 612,500 | $3,439,000 | 1.24% |
| BRIDGER MANAGEMENT, LLC | 2,334,196 | $13,107,000 | 1.08% |
| Sofinnova Investments, Inc. | 1,733,628 | $9,734,000 | 0.88% |
| PURA VIDA INVESTMENTS, LLC | 354,719 | $1,992,000 | 0.34% |
| 683 Capital Management, LLC | 400,000 | $2,246,000 | 0.25% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 649,460 | $3,646,000 | 0.23% |
| Artal Group S.A. | 900,000 | $5,054,000 | 0.20% |
| Frontier Wealth Management LLC | 226,750 | $1,273,000 | 0.19% |